A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection
- PMID: 6736638
- PMCID: PMC2129324
- DOI: 10.1017/s0022172400064500
A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection
Abstract
Three hundred volunteers were divided into two age groups, 14-30 years and 31-60 years. Each participant was immunized intramuscularly with a subunit, whole virus or absorbed whole virus vaccine, containing A/Bangkok/1/79 (H3N2), A/Brazil/11/78 (H1N1) and B/Singapore/222/79 influenza virus. Serum haemagglutination-inhibition (HI) antibody response, protection, and reactogenicity were studied after one and two doses of the vaccines. Primary immunization induced much higher percentages of HI antibody titres greater than or equal to 100 against all three vaccine viruses and much higher geometric mean titres (GMT) in volunteers with pre-immunization titres greater than or equal to 18 as compared to those with pre-immunization titres less than 18. Secondary immunization did not result in an increase of GMTs or antibody titres greater than or equal to 100 in volunteers with pre-immunization titres less than 18. On the whole, the response to the subunit vaccine was similar to that to the other two vaccines. To influenza B/Singapore/222/79 virus the response was lowest after administration of the whole virus vaccine in the age group 31-60 years. Over 50% of the HI titres greater than or equal to 100 found after immunization in the different vaccine and age groups were still present after one year. Serologically established infections during the winter months following immunization amounted to 15% in the subunit vaccine group, 6% in the whole virus vaccine group, and 10% in the adsorbed whole virus vaccine group. Local and systemic reactions to all three vaccines were mild in nature. Local reactions after primary immunization were much less frequent following administration of the subunit vaccine as compared to the other two vaccines, especially in the younger age group. In comparison to primary immunization, after booster immunization the incidence of local reactions was higher for the subunit vaccine and lower for the adsorbed whole virus vaccine. In the age group 14-30 years the incidence of local reactions after primary as well as booster immunization was much greater in females than in males, especially when the adsorbed whole virus vaccine was used.
Similar articles
-
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.J Hyg (Lond). 1983 Jun;90(3):351-9. doi: 10.1017/s0022172400028989. J Hyg (Lond). 1983. PMID: 6863909 Free PMC article.
-
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.J Hyg (Lond). 1983 Jun;90(3):361-70. doi: 10.1017/s0022172400028990. J Hyg (Lond). 1983. PMID: 6863910 Free PMC article.
-
A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.J Hyg (Lond). 1983 Feb;90(1):107-15. doi: 10.1017/s0022172400063907. J Hyg (Lond). 1983. PMID: 6822725 Free PMC article.
-
Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.Semin Pediatr Infect Dis. 2002 Apr;13(2):112-9. doi: 10.1053/spid.2002.122998. Semin Pediatr Infect Dis. 2002. PMID: 12122949 Review.
-
Safety, immunogenicity and efficacy of influenza vaccine in children.J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S83-90. doi: 10.2223/JPED.1494. Epub 2006 Jun 21. J Pediatr (Rio J). 2006. PMID: 16794746 Review.
Cited by
-
Immunogenicity and cross protective ability of the central VP2 amino acids of infectious pancreatic necrosis virus in Atlantic salmon (Salmo salar L.).PLoS One. 2013;8(1):e54263. doi: 10.1371/journal.pone.0054263. Epub 2013 Jan 21. PLoS One. 2013. PMID: 23349841 Free PMC article.
-
Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.Hum Vaccin Immunother. 2013 Oct;9(10):2049-59. doi: 10.4161/hv.25735. Epub 2013 Jul 24. Hum Vaccin Immunother. 2013. PMID: 23884239 Free PMC article.
-
Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature.Clin Drug Investig. 1998;15(1):1-12. doi: 10.2165/00044011-199815010-00001. Clin Drug Investig. 1998. PMID: 18370460
-
Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.BMJ. 1993 Oct 16;307(6910):988-90. doi: 10.1136/bmj.307.6910.988. BMJ. 1993. PMID: 8241913 Free PMC article. Clinical Trial.
-
Postvaccinial (influenza) disseminated encephalopathy (Brown-Sequard syndrome).J Natl Med Assoc. 1995 Sep;87(9):705-8. J Natl Med Assoc. 1995. PMID: 9583968 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical